Genetic Leap
Genetic disease drug development
- AI & machine learning
- Pharma & life sciences
About Genetic Leap
Using AI, the company pioneers disease cure since 2016, controlling gene expression of undruggable targets like MYC and IL-2 via pill delivery
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- new york, United States
- Founded
- 2017
- Revenue
- $5.3M – $41.6MTamtam estimate
- Website
- genetic-leap.com
Genetic Leap at a glance
Genetic Leap is a company in the Biotechnology Research industry, headquartered in new york, United States.
Genetic Leap was founded in 2017.
Genetic Leap has 1–10 employees.
Genetic Leap's revenue is $5.3M – $41.6M (Tamtam estimate).
Frequently asked questions about Genetic Leap
What is Genetic Leap's revenue?
Tamtam estimates Genetic Leap's annual revenue at $5.3M – $41.6M.
How many employees does Genetic Leap have?
Genetic Leap has 1–10 employees.
Where is Genetic Leap headquartered?
Genetic Leap is headquartered in new york, United States.
Selling to companies like Genetic Leap?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies